Comparison of Intravenous Ganciclovir Followed by Oral Acyclovir with Intravenous Ganciclovir Alone for Prevention of Cytomegalovirus and Epstein‐Barr Virus Disease After Liver Transplantation in Children
Open Access
- 1 December 1997
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 25 (6) , 1344-1349
- https://doi.org/10.1086/516139
Abstract
A randomized trial was performed to compare the sequential use of 2 weeks of intravenous ganciclovir (10 mg/[kgrd]) followed by 50 weeks of high-doseKeywords
This publication has 2 references indexed in Scilit:
- Modelling survival dataPublished by Springer Nature ,1994
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989